Sponsor:
AstraZeneca
Code:
NCT05061550
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Durvalumab
Oleclumab
Monalizumab
Dato-DXd
AZD0171
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations